OncologyDr. Shubham JainCancer Warning Signs

Senior Director, Surgical Oncology, Fortis Hospital, Vasant Kunj, New Delhi

Part 9 of 10 in When to Suspect Cancer and How to Refer

Common Myths About Cancer Diagnosis and Treatment

January 25, 2026

Dr. Shubham Jain addressed several myths that he says routinely keep patients from seeking or completing timely cancer treatment.

Biopsy does not spread cancer

The most persistent myth he encounters is the fear that a biopsy will cause cancer to spread. He is direct on this point: a biopsy, planned and performed correctly, will not lead to the spread of cancer, and it remains one of the most crucial tests a cancer patient needs, since it confirms the diagnosis and guides every subsequent treatment decision.

Cancer is not a patient’s fault

He also challenges the belief, once widely held, that cancer happens only because of a patient’s own indulgences, such as tobacco or alcohol use. More cases are now understood to arise from environmental exposure or genetics rather than personal fault, and Dr. Jain stresses that destigmatising patients suffering from cancer is important, since stigma is itself a barrier that keeps patients away from timely treatment.

This article is based on a Jivo Masterclass session conducted by Dr. Shubham Jain, Senior Director, Surgical Oncology, Fortis Hospital, Vasant Kunj, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a cancer diagnosis or a second opinion? Get in touch with the Jivo team

This guide is based on a live Jivo Masterclass — Dr. Shubham Jain taught doctors across Africa on January 25, 2026.

FROM THE LIVE Q&A

DR

Dr. Oronana Paul Edugbo

What is your take on mebendazole and ivermectin as adjunct tablets for cancer treatment?

SJ

Dr. Shubham Jain

These are being evaluated as adjuvant therapy for cancer, but there is not yet sufficient scientific data backing them, so standard chemotherapy remains the primary reliance. What is showing real results is targeted therapy and immunotherapy, where survival has improved and recurrences and side effects have reduced. Cost has been a sore point since these are expensive medicines, but with generic versions now available and patient assistance programmes extending to international patients, these costs are coming down.

See all 12 questions from this masterclass →

Book a Consultation with Dr. Shubham Jain

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

How do you see complications from radiotherapy on the left side of the chest?

The most common complication with radiotherapy for left-sided breast cancers is cardiotoxicity. Radiation oncologists manage this with deep inspiratory breath-hold and gating techniques, training the patient to hold their breath during the active phase of radiotherapy so toxicity to the heart is reduced, chest wall motion is reduced, and radiation is delivered accurately to the target volume. More precise machines such as IGRT and 4D-CRT are also improving precision for left-sided breast and chest wall tumours.

Which cancers have patient assistance programmes, and how do they work, and who is eligible?

Until very recently, patient assistance programmes for targeted therapy and immunotherapy were only available to Indian patients. Because these drugs are costly, companies assist with procuring them at up to a half or a third of the usual cost, which is out of reach for many domestic Indian patients too because of regulations. These regulations are now relaxing, and more international patients are able to receive the benefit of these programmes.

On the slide about smokers, it said 20 packs. Does that mean 20 packs smoked per day?

Not 20 packs per day, that would be 400 cigarettes a day, which is not possible. Pack-years is the number of packs smoked per day multiplied by the number of years smoked. Two packs a day for ten years makes 20 pack-years, as does one pack a day for twenty years, or half a pack a day for forty years.

How should a doctor practising in a resource-constrained setting, without enough diagnostic facilities to screen large populations, know which symptoms genuinely warrant referral and which could be a false alarm?

Any suspected cancer requires resources for investigation and treatment, so it should be evaluated at a good high-volume centre that gives the best chance of cure. It is difficult to assess the outcome or treatment at an initial stage, so the primary reliance has to be on the clinical signs and symptoms already discussed, which are the basis for suggesting a patient be evaluated at a high-volume centre.

Can you tell us something about malignant wounds?

A malignant wound anywhere needs to be confirmed on biopsy to establish the exact reason for it, and it should not be expected to heal on its own. It should be subjected to a biopsy to confirm the nature of the malignancy and the treatment options, with appropriate imaging to understand the underlying structures involved, and surgery offered if the wound is resectable.

Does having a biopsy cause cancer to spread?

No. A biopsy, if planned and performed correctly, will not cause cancer to spread, and it remains one of the most crucial tests for confirming a diagnosis and guiding treatment.

Is cancer always caused by a patient’s own habits, like smoking or drinking?

No. While tobacco and alcohol use are risk factors for some cancers, many cases are now understood to arise from environmental exposure or genetics rather than a patient’s own fault.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion